Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
3.540
-0.010 (-0.28%)
At close: Jun 27, 2025, 4:00 PM
3.550
+0.010 (0.28%)
After-hours: Jun 27, 2025, 4:34 PM EDT
Cytek Biosciences Market Cap
Cytek Biosciences has a market cap or net worth of $448.37 million as of June 27, 2025. Its market cap has decreased by -46.30% in one year.
Market Cap
448.37M
Enterprise Value
198.66M
1-Year Change
-46.30%
Ranking
Category
Stock Price
$3.54
Market Cap Chart
Since the IPO on July 23, 2021, Cytek Biosciences's market cap has decreased from $2.26B to $448.37M, a decrease of -80.17%. That is a compound annual growth rate of -33.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 449.64M | -46.21% |
| Dec 31, 2024 | 835.98M | -32.38% |
| Dec 29, 2023 | 1.24B | -10.21% |
| Dec 30, 2022 | 1.38B | -36.91% |
| Dec 31, 2021 | 2.18B | -3.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.24B |
| Johnson & Johnson | 366.76B |
| AbbVie | 327.47B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 278.98B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 233.24B |
| AstraZeneca | 215.99B |